199 related articles for article (PubMed ID: 29363944)
1. Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice.
Fleming KA; Ericson MD; Freeman KT; Adank DN; Lunzer MM; Wilber SL; Haskell-Luevano C
ACS Chem Neurosci; 2018 May; 9(5):1141-1151. PubMed ID: 29363944
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.
Fleming KA; Freeman KT; Ericson MD; Haskell-Luevano C
J Med Chem; 2018 Sep; 61(17):7729-7740. PubMed ID: 30035543
[TBL] [Abstract][Full Text] [Related]
3. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology.
Ericson MD; Wilczynski A; Sorensen NB; Xiang Z; Haskell-Luevano C
J Med Chem; 2015 Jun; 58(11):4638-47. PubMed ID: 25898270
[TBL] [Abstract][Full Text] [Related]
5. Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.
Ericson MD; Koerperich ZM; Freeman KT; Fleming KA; Haskell-Luevano C
ACS Chem Neurosci; 2018 Dec; 9(12):3015-3023. PubMed ID: 29924583
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
[TBL] [Abstract][Full Text] [Related]
7. Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor.
Ericson MD; Freeman KT; Schnell SM; Fleming KA; Haskell-Luevano C
J Med Chem; 2017 Oct; 60(19):8103-8114. PubMed ID: 28813605
[TBL] [Abstract][Full Text] [Related]
8. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
[TBL] [Abstract][Full Text] [Related]
9. A Macrocyclic Agouti-Related Protein/[Nle
Ericson MD; Freeman KT; Schnell SM; Haskell-Luevano C
J Med Chem; 2017 Jan; 60(2):805-813. PubMed ID: 28045525
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.
Koerperich ZM; Ericson MD; Freeman KT; Speth RC; Pogozheva ID; Mosberg HI; Haskell-Luevano C
J Med Chem; 2020 Mar; 63(5):2194-2208. PubMed ID: 31845801
[TBL] [Abstract][Full Text] [Related]
11. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
[TBL] [Abstract][Full Text] [Related]
13. Peptoid NPhe
Ericson MD; Freeman KT; Haskell-Luevano C
ACS Med Chem Lett; 2020 Oct; 11(10):1942-1948. PubMed ID: 33062177
[TBL] [Abstract][Full Text] [Related]
14. 1,2,3-Triazole Rings as a Disulfide Bond Mimetic in Chimeric AGRP-Melanocortin Peptides: Design, Synthesis, and Functional Characterization.
Tala SR; Singh A; Lensing CJ; Schnell SM; Freeman KT; Rocca JR; Haskell-Luevano C
ACS Chem Neurosci; 2018 May; 9(5):1001-1013. PubMed ID: 29257879
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jun; 45(13):2801-10. PubMed ID: 12061882
[TBL] [Abstract][Full Text] [Related]
16. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
[TBL] [Abstract][Full Text] [Related]
18. Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor.
Navarro M; Cubero I; Chen AS; Chen HY; Knapp DJ; Breese GR; Marsh DJ; Thiele TE
Alcohol Clin Exp Res; 2005 Jun; 29(6):949-57. PubMed ID: 15976520
[TBL] [Abstract][Full Text] [Related]
19. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
[TBL] [Abstract][Full Text] [Related]
20. Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist.
Ericson MD; Doering SR; Larson CM; Freeman KT; LaVoi TM; Donow HM; Santos RG; Cho RH; Koerperich ZM; Giulianotti MA; Pinilla C; Houghten RA; Haskell-Luevano C
J Med Chem; 2021 Oct; 64(19):14860-14875. PubMed ID: 34592820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
